Transfection is a technique used to introduce foreign genetic material, such as DNA or RNA, into cells. It has various applications in biomedical research, biotechnology, and gene therapy. Transfection reagents and equipment are used to facilitate this process.
The global transfection reagents and equipment market was valued at US$ 1,066.5 Mn in 2022 and is forecast to reach a value of US$ 2,171.7 Mn by 2030 at a CAGR of 9.3% between 2023 and 2030.
The transfection reagents and equipment market is a growing industry that plays a crucial role in molecular biology and genetic research. Transfection is the process of introducing foreign nucleic acids into cells, and it requires specialized reagents and equipment to accomplish successfully.
Get More Insights [PDF], Click Here: https://www.coherentmarketinsights.com/market-insight/transfection-reagents-and-equipment-market-5659
One of the main drivers of the transfection reagents and equipment market is the increasing demand for gene therapy and genetic research. Gene therapy is an emerging field that aims to cure genetic diseases by introducing functional copies of genes into a patient's cells. This requires the use of transfection reagents and equipment to deliver the therapeutic genes into the patient's cells.
In addition to gene therapy, transfection is also used in basic research to study gene expression and function. This has led to the development of a wide range of transfection reagents and equipment to meet the diverse needs of researchers.
The transfection reagents and equipment market is a rapidly growing industry due to the increasing demand for genetic research and gene therapy. Some of the key players in the market include Thermo Fisher Scientific, Promega Corporation, QIAGEN, Bio-Rad Laboratories, Lonza, and Roche.
Transfection reagents can be classified into various categories, including lipids, polymers, and cationic molecules. Lipid-based transfection reagents, also known as liposomes, are the most widely used transfection reagents due to their high efficiency and low toxicity. Polyethylenimine (PEI) is another commonly used transfection reagent that is efficient but can be toxic to cells.
Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/5659
Transfection equipment includes electroporators, microinjectors, and gene guns. Electroporators are the most commonly used transfection equipment and use an electrical pulse to create transient pores in the cell membrane, allowing the genetic material to enter the cell. Microinjectors and gene guns are less commonly used but can be more precise in their delivery of genetic material.
Overall, the transfection reagents and equipment market is expected to continue to grow as genetic research and gene therapy continue to expand
3 February 2020 - The Global Transfection Reagent & Equipment Market size is estimated to reach USD 1.08 billion by 2022, exhibiting a 7.4% CAGR during the forecast period.
The aforementioned factor is attributive to drive the segment revenue potentially in the coming years.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/transfection-reagents-equipment-marketPatent cliff generated in recent years is pronouncing the need for production of several moieties which depends on the laboratory analysis thus inducing industrial growth in this market.
Anticipated rise in the analytical methods is expected to increase the adoption of such technologies in the coming years.Additionally, with established healthcare infrastructure and reimbursement policy, many pharma companies are expanding their business in western geographic segments which would induce innovation and growth in the biotechnology industry over the forecasted period.Method InsightsElectroporation method for conducting transfection process holds the largest share of the revenue.
However, the misuse of this method has caused cell damage which is expected to slow down its adoption.Liposomal method is second only to the electroporation method of transfection.
Vaccine biopharmaceuticals production requires substantial usage of gene expression methods based on the principles of transfection.Proteomic analyzers and cytology-based programs (for research purpose) are expected to witness demand in biomedical and oncology studies.
This factor is expected to fuel progress in the coming years.View Full Report with TOC @ https://www.millioninsights.com/industry-reports/transfection-reagents-equipment-market/request-sampleRegional InsightsNorth American region witnessed highest penetration in 2016 owing to the presence of large number of research and biopharmaceutical production institutes, biosimilar drugs, vaccines, and clinical organizations for RWith the rise in number of academic institutes engaged in basic research for protein and genetic research which are highly supported by the government, the market revenue for transfection is anticipated to witness potential increment.
